Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials von Rosenstock, Julio, Marquard, Jan, Laffel, Lori M, Neubacher, Dietmar, Kaspers, Stefan, Cherney, David Z, Zinman, Bernard, Skyler, Jay S, George, Jyothis, Soleymanlou, Nima, Perkins, Bruce A

Volltext

Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment von Marquard, Jan, Otter, Silke, Welters, Alena, Stirban, Alin, Fischer, Annelie, Eglinger, Jan, Herebian, Diran, Kletke, Olaf, Klemen, Maša Skelin, Stožer, Andraž, Wnendt, Stephan, Piemonti, Lorenzo, Köhler, Martin, Ferrer, Jorge, Thorens, Bernard, Schliess, Freimut, Rupnik, Marjan Slak, Heise, Tim, Berggren, Per-Olof, Klöcker, Nikolaj, Meissner, Thomas, Mayatepek, Ertan, Eberhard, Daniel, Kragl, Martin, Lammert, Eckhard

Volltext

Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers von Welters, Alena, Lerch, Christian, Kummer, Sebastian, Marquard, Jan, Salgin, Burak, Mayatepek, Ertan, Meissner, Thomas

Volltext

A Model-Informed Drug Development (MIDD) Approach for a Low Dose of Empagliflozin in Patients with Type 1 Diabetes von Johnston, Curtis K, Eudy-Byrne, Rena J, Elmokadem, Ahmed, Nock, Valerie, Marquard, Jan, Soleymanlou, Nima, Riggs, Matthew M, Liesenfeld, Karl-Heinz

Volltext

Glucose metabolism and neurological outcome in congenital hyperinsulinism von Ludwig, Anja, Ziegenhorn, Katja, Empting, Susann, Meissner, Thomas, MD, PhD, Marquard, Jan, MD, Holl, Reinhard, MD, PhD, Mohnike, Klaus, MD, PhD

Volltext

RATES OF HEART FAILURE (HF) AND OTHER CARDIOVASCULAR EVENTS FOLLOWING ST-ELEVATED MYOCARDIAL INFARCTION IN THE UNITED STATES: A TARGETED LITERATURE REVIEW von Deighton, Alison M., Marquard, Jan, Korpach, Sarah, Taiji, Riley, Szabo, Shelagh, Donato, Bonnie M. Korenblat

Volltext

Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review von Farsani, Soulmaz Fazeli, Brodovicz, Kimberly, Soleymanlou, Nima, Marquard, Jan, Wissinger, Erika, Maiese, Brett A

Volltext

1140-P: Impact of Empagliflozin on Hyperfiltration in Youth with Type 2 Diabetes-Post Hoc Analysis of the DINAMO and DINAMO MONO Trials von Bjornstad, Petter, Danne, Thomas, Tamborlane, William V, Klingensmith, Georgeanna J, Schueler, Elke, Tartakovsky, Igor, Marquard, Jan, Zeitler, Philip, Willi, Steven M, Laffel, Lori M

Volltext

Kidney Effects of Empagliflozin in People with Type 1 Diabetes von Cherney, David Z I, Bjornstad, Petter, Perkins, Bruce A, Rosenstock, Julio, Neubacher, Dietmar, Marquard, Jan, Soleymanlou, Nima

Volltext

Rare forms of congenital hyperinsulinism von Marquard, Jan, MD, Palladino, Andrew A., MD, Stanley, Charles A., MD, Mayatepek, Ertan, MD, Meissner, Thomas, MD

Volltext

Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4‐week, double‐blind, randomized, placebo‐controlled phase 2 trial von Shimada, Akira, Hanafusa, Toshiaki, Yasui, Atsutaka, Lee, Ganghyuck, Taneda, Yusuke, Sarashina, Akiko, Shiki, Kosuke, George, Jyothis, Soleymanlou, Nima, Marquard, Jan

Volltext

Kidney Effects of Empagliflozin in People with Type 1 Diabetes: PO1008 von Cherney, David, Bjornstad, Petter, Perkins, Bruce A., Rosenstock, Julio, Neubacher, Dietmar, George, Jyothis T., Marquard, Jan, Soleymanlou, Nima

Volltext

164-LB: Durable Improvement in HbA1c in Youth-Onset T2D—A Post Hoc Analysis of the DINAMO Trial of Empagliflozin and Linagliptin vs. Placebo von LAFFEL, LORI M., DANNE, THOMAS, TAMBORLANE, WILLIAM V., KLINGENSMITH, GEORGEANNA J., NEUBACHER, DIETMAR, TARTAKOVSKY, IGOR, MARQUARD, JAN, ZEITLER, PHILIP, WILLI, STEVEN M.

Volltext

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes von Bjornstad, Petter, Laffel, Lori, Tamborlane, William V, Simons, Gudrun, Hantel, Stefan, von Eynatten, Maximilian, George, Jyothis, Marquard, Jan, Cherney, David Z I

Volltext

Population Pharmacokinetic– Pharmacodynamic Analysis to Characterize the Effect of Empagliflozin on Renal Glucose Threshold in Patients With Type 1 Diabetes Mellitus von Mondick, John, Riggs, Matthew, Kaspers, Stefan, Soleymanlou, Nima, Marquard, Jan, Nock, Valerie

Volltext

Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in youth with type 2 diabetes: a multicentre, randomised,... von Laffel, Lori M., Danne, Thomas, Klingensmith, Georgeanna J., Tamborlane, William V., Willi, Steven, Zeitler, Philip, Neubacher, Dietmar, Marquard, Jan

Volltext

994-P: DINAMO—Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents with Type 2 Diabetes (T2D) : Innovative Study Design and Baseline Characteristics von LAFFEL, LORI M., DANNE, THOMAS, TAMBORLANE, WILLIAM V., KLINGENSMITH, GEORGEANNA J., SCHROEDER, CHRISTY, NEUBACHER, DIETMAR, SOLEYMANLOU, NIMA, MARQUARD, JAN, ZEITLER, PHILIP, WILLI, STEVEN M.

Volltext

Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicen... von Laffel, Lori M, Danne, Thomas, Klingensmith, Georgeanna J, Tamborlane, William V, Willi, Steven, Zeitler, Philip, Neubacher, Dietmar, Marquard, Jan, Bardymova, Tatiana, Barrientos Perez, Margarita, Bethin, Kathleen, Bjornstad, Petter, Bondar, Irina, Chen, Mimi, Choi, Jin-Ho, Clements, Mark A, Colomar, Javier Ricardo, Daniels, Mark, Deerochanawong, Chaicharn, Desai, Vivek S, Desmangles, Jean-Claude G, Dillon, Robert G, Dixit, Naznin M, Du, Hongwei, Edelen, Rachel, Espinoza Peralta, Diego, Felipe Gacioppo, María Verónica, Ferraz, Tania Maria Bulcão Lousada, Galkina, Galina, Gallagher, Mary Patricia, George, Minu, Gonzalez, Edgar, Gottschalk, Michael Everett, Guido, Giancarlo, Hassan, Amir Ali, Hershkovitz, Eli, Huerta-Saenz, Lina P, Hwang, Jin Soon, Ibarra Gomez, Jaime Orlando, Irizarry Gonzalez, Lydia, Jain, Nina, Jelley, David H, Kim, Ho-Seong, Kovalenko, Tatiana, Laffel, Lori Michelle B, Leichter, Steven B, Liberatore Jr, Raphael Del Roio, Lynch, Jane, Mahmud, Farid Hussain, Malievskiy, Oleg Arturovich, Muir, Andrew, Nelson, Bryce A, Nevarez Ruiz, Luis Alejandro, Olson, Micah L, Pelayo Orozco, Emilia Susana, Peterkova, Valentina, Ramírez Mendoza, Fernando Ramón, Reddy, Konda Mohan, Rodriguez, Henry, Saenz, Javier Andres, Samoilova, Julia, Schwab, Karl-Otfried, Shah, Sejal H, Shehadeh, Naim, Shoemaker, Ashley H, Skorodok, Yulia, Sobolev, Aleksandr, Solís, Silvana Ernestina, Srinivasan, Shylaja, Tamborlane, William V, Tsalikian, Eva, Valeeva, Farida, Vance, Carl D, Velasquez-Mieyer, Pedro A, Violante Ortiz, Rafael Margarito, Votyakova, Olga, Wei, Haiyan, Weinstock, Ruth S, Wheeler, Mark D, Wicklow, Brandy Alexandra, Willi, Steven M, Wintergerst, Kupper A, Wolf, Risa M, Wood, Jamie Ruth, Yaliwal, Chandan, Yupanqui Lozno, Hernán

Volltext

Pharmacometrics-Enhanced Bayesian Borrowing for Pediatric Extrapolation - A Case Study of the DINAMO Trial von Sailer, Martin Oliver, Neubacher, Dietmar, Johnston, Curtis, Rogers, James, Wiens, Matthew, Pérez-Pitarch, Alejandro, Tartakovsky, Igor, Marquard, Jan, Laffel, Lori M

Volltext

Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop von Barrett, Jeffrey S., Bucci‐Rechtweg, Christina, Amy Cheung, S. Y., Gamalo‐Siebers, Margaret, Haertter, Sebastian, Karres, Janina, Marquard, Jan, Mulugeta, Yeruk, Ollivier, Cecile, Strougo, Ashley, Yanoff, Lisa, Yao, Lynne, Zeitler, Philip

Volltext